Brain metastases: vizsgálatok itt: Kína
56 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC
- Where
- Fuzhou, Shanghai, Tianjin
- Életkor
- 18 év and over
- People
- 48
- Run by
- Wayshine Biopharm, Inc.
See details and how to joinNCT07206498 - 2. fázisTaking peopleBrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 39
- Run by
- Fudan University
See details and how to joinNCT06793332 - No phaseTaking peopleePRO in Advanced Lung Cancer: Emotional Distress, Symptom Burden, Brain Metastasis
- Where
- Hubei
- Életkor
- 18 év and over
- People
- 200
- Run by
- Qian Chu
See details and how to joinNCT07912190 - 1/2. fázisTaking peoplePhase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 139
- Run by
- Fudan University
See details and how to joinNCT07134153 - 1/2. fázisTaking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Beijing, Jinan, Shanghai, Suzhou
- Életkor
- 18 év and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - 2. fázisTaking peopleA Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined With Capecitabine in the Treatment of Active Brain Metastasis of TNBC
- Where
- Zhengzhou
- Életkor
- 18 év and over
- People
- 48
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06598046 - 2. fázisTaking peopleTrastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
- Where
- Zhengzhou
- Életkor
- 18 év and over
- People
- 224
- Run by
- Henan Cancer Hospital
See details and how to joinNCT07100600 - 3. fázisTaking peopleSRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 340
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06457906 - 2. fázisTaking peopleT-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 202
- Run by
- Fudan University
See details and how to joinNCT07152782 - 2. fázisTaking peopleT-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 140
- Run by
- Fudan University
See details and how to joinNCT07150208 - 2. fázisTaking peopleStudy of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 58
- Run by
- Fudan University
See details and how to joinNCT07638852 - 2. fázisTaking peopleTY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 420
- Run by
- TYK Medicines, Inc
See details and how to joinNCT05948813 - 3. fázisTaking peopleA Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases
- Where
- Guangdong
- Életkor
- 18 év and over
- People
- 380
- Run by
- Allist Pharmaceuticals, Inc.
See details and how to joinNCT06970639 - 2. fázisNot yet taking people in KínaCulmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases
- Where
- Anyang, Chengdu, Dalian, Guangzhou, Hangzhou, Nanchang, Nanjing, Shijiazhuang, Zhengzhou
- Életkor
- 18 év to 80 év
- People
- 40
- Run by
- Sun Yat-sen University
See details and how to joinNCT07745257 - Korai 1. fázisNot yet taking people in KínaQH101 Cell Injection in Patients With Brain, Brain (Spinal) Meninges, and Spinal Cord Metastatic Malignant Solid Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 7
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07656103 - No phaseTaking peopleA Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 100
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06839547 - 2. fázisTaking peopleEvaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain Metastasis
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 102
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06839560 - No phaseNot yet taking people in KínaImpact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 150
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT07638709 - 2. fázisTaking peopleSac-TMT Combined With Bevacizumab in TNBC With Brain Metastases
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 24
- Run by
- Fudan University
See details and how to joinNCT07623577 - 2. fázisTaking peopleEfficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
- Where
- Anyang, Beijing, Bengbu, Changchun, Chongqing, Guangzhou, Hangzhou, Harbin, Hefei, Liuzhou, Luoyang, Nanjing, Nanning, Neijiang, Shijiazhuang, Tianjin, Ürümqi, Wuhan, Xi'an, Xiangyang, Yinchuan, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 52
- Run by
- Shanghai Pharmaceuticals Holding Co., Ltd
See details and how to joinNCT05872347 - 2. fázisNot yet taking people in KínaBrain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 46
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07539753 - No phaseTaking peopleNK Cell Therapy for Malignant Solid Brain Tumors
- Where
- Beijing, Qinhuangdao, Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 27
- Run by
- Peking University Third Hospital
See details and how to joinNCT07552233 - 2/3. fázisNot yet taking people in KínaComparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases:
- Where
- Haikou
- Életkor
- 18 év to 75 év
- People
- 400
- Run by
- The Second Affiliated Hospital of Hainan Medical University
See details and how to joinNCT07542288 - 3. fázisTaking peopleBevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
- Where
- Chongqing, Guangzhou
- Életkor
- 18 év and over
- People
- 220
- Run by
- Sun Yat-sen University
See details and how to joinNCT07481786 - 2. fázisTaking peopleStudy of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 150
- Run by
- Henan Cancer Hospital
See details and how to joinNCT05769010